207,482 Shares in Acadia Healthcare Company, Inc. $ACHC Acquired by Legal & General Group Plc

Legal & General Group Plc acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 207,482 shares of the company’s stock, valued at approximately $6,127,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Clough Capital Partners L P bought a new position in shares of Acadia Healthcare in the 1st quarter valued at $5,359,000. Deutsche Bank AG acquired a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $49,746,000. Lisanti Capital Growth LLC bought a new stake in Acadia Healthcare during the 2nd quarter worth $4,502,000. Bank of America Corp DE increased its holdings in Acadia Healthcare by 64.7% in the 1st quarter. Bank of America Corp DE now owns 1,231,172 shares of the company’s stock worth $28,797,000 after purchasing an additional 483,649 shares in the last quarter. Finally, Royal Bank of Canada raised its position in Acadia Healthcare by 7,896.1% in the first quarter. Royal Bank of Canada now owns 278,265 shares of the company’s stock valued at $6,508,000 after purchasing an additional 274,785 shares during the last quarter.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. UBS Group raised their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. TD Cowen upped their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Barclays raised their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Price Performance

Shares of ACHC opened at $27.75 on Thursday. The firm has a market cap of $2.58 billion, a PE ratio of -2.23, a price-to-earnings-growth ratio of 9.10 and a beta of 0.62. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83. The business’s 50 day moving average price is $30.64 and its two-hundred day moving average price is $26.42. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter last year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.